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Microglia and reactive astrocytes accumulate in the spinal cord of rats expressing the
Amyotrophic lateral sclerosis (ALS)-linked SOD1G93A mutation.We previously reported that
the rapid progression of paralysis in ALS rats is associated with the appearance of prolifer-
ative astrocyte-like cells that surround motor neurons.These cells, designated as Aberrant
Astrocytes (AbA cells) because of their atypical astrocytic phenotype, exhibit high toxicity
tomotor neurons. However, the cellular origin of AbA cells remains unknown. BecauseAbA
cells are labeled with the proliferation marker Ki67, we analyzed the phenotypic makers of
proliferating glial cells that surround motor neurons by immunohistochemistry.The number
of Ki67+AbA cells sharply increased in symptomatic rats, displaying large cell bodies with
processes embracing motor neurons. Most were co-labeled with astrocytic marker GFAP
concurrently with the microglial markers Iba1 and CD163. Cultures of spinal cord prepared
from symptomatic SOD1G93A rats yielded large numbers of microglia expressing Iba1,
CD11b, and CD68. Cells sorted for CD11b expression by ﬂow cytometry transformed
into AbA cells within two weeks. During these two weeks, the expression of microglial
markers largely disappeared, while GFAP and S100β expression increased.The phenotypic
transition to AbA cells was stimulated by forskolin. These ﬁndings provide evidence for a
subpopulation of proliferating microglial cells in SOD1G93A rats that undergo a phenotypic
transition into AbA cells after onset of paralysis that may promote the fulminant disease
progression. These cells could be a therapeutic target for slowing paralysis progression
in ALS.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) may be considered as a
paradigm of neurodegeneration involving the progressive death of
upper and lower motor neurons (Cleveland and Rothstein, 2001;
Boillee et al., 2006a). A consistent neuropathological feature of
ALS is the extensive inﬂammation around motor neurons and
axonal degeneration, evidenced by the accumulation of reactive
astrocytes, activated microglia and lymphocytes (Engelhardt et al.,
1993; Barbeito et al., 2004; Ilieva et al., 2009; Graber et al., 2010).
Neuroinﬂammation is evident in rodent models of inherited ALS
overexpressing mutant Cu/Zn superoxide dismutase (SOD1) and
in ALS human patients (Gurney et al., 1994; Bruijn et al., 1997;
Howland et al., 2002; McGeer and McGeer, 2002; Appel, 2009).
Several studies suggest that glial cells, including astrocytes and
microglia, play a pathogenic role inALS through promotingmotor
neuron death and spreading paralysis after disease onset (Hall
et al., 1998; Barbeito et al., 2004; Sargsyan et al., 2005; Boillee et al.,
2006b; Papadeas et al., 2011). These observations suggest that ther-
apeutics targeting the inﬂammatory response of glial cells could
slow ALS progression.
We have recently reported the isolation of astrocytes-like glial
cells with an aberrant phenotype (AbA cells) from primary
spinal cord cultures of symptomatic transgenic rats expressing
the SOD1G93A mutation (Diaz-Amarilla et al., 2011). Isolation
was based on AbA cell’s marked proliferative capacity and lack
of replicative senescence. These cells secrete soluble factors that
induce motor neuron death with a higher potency than neonatal
transgenic astrocytes. Aberrant astrocytes only appear after dis-
ease onset in SOD1G93A rats and are localized adjacent to motor
neurons, suggesting a link between generation of AbA cells and
the progression of paralysis. However, the origin of AbA cells
remains unknown. Because AbA cells actively proliferate in the
degenerating spinal cord, we hypothesized they could originate
from glial progenitors with a high proliferative potential. Previ-
ous studies have identiﬁed phagocytic microglia as well as NG2+
glial progenitors that proliferate during the active phase of motor
neuron degeneration in ALS mice and rats (Magnus et al., 2008;
Kang et al., 2010; Sanagi et al., 2010). Because we have previously
shown that AbA cells do not express NG2 (Diaz-Amarilla et al.,
2011), we examined whether AbA cells might be derived from
Frontiers in Cellular Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 274 | 1
“fncel-07-00274” — 2013/12/23 — 19:00 — page 2 — #2
Trias et al. Phenotypic transition of microglia into astrocyte-like cells
microglia proliferating adjacent to motoneurons. In this study, we
have characterized both in vivo and ex vivo the phenotype of pro-
liferating glial cells in symptomatic ALS rats and found evidence
that neurotoxic AbA cells result from a phenotypic transition from
activated microglial cells.
MATERIALS AND METHODS
ANIMALS
All procedures using laboratory animals were performed in accor-
dance with the international guidelines for the use of live animals
and were approved by the Institutional Animal Committee. Male
hemizygous NTac:SD-TgN(SOD1G93A)L26H rats (Taconic), orig-
inally developed by Howland et al. (2002), were bred locally
by crossing with wild-type Sprague–Dawley female rats. Male
SOD1G93A progenies were used for further breeding to maintain
the line. Rats were housed in a centralized animal facility with a
12-h light-dark cycle with ad libitum access to food and water.
Symptomatic disease onset was determined by periodic clinical
examination for abnormal gait, typically expressed as subtle limp-
ing or dragging of one hind limb. Rats were killed when they
reached the end stage of the disease. Both the onset of symp-
tomatic disease (160–170 d) and lifespan (180–195 d) in our
colony were delayed considerably compared with earlier reports
(Howland et al., 2002). This study was carried out in strict accor-
dance with the IIBCE Bioethics Committee’s requirements and
under the current ethical regulations of the Uruguayan Law N◦
18.611 for animal experimentation that follows the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health (USA). All surgery was performed under 90% ketamine –
10% xylazine anesthesia, and all efforts were made to minimize
suffering, discomfort or stress.
CELL CULTURE FROM END-STAGE SYMPTOMATIC SOD1G93A RATS
Microglia cells were obtained from adult spinal cord of symp-
tomatic SOD1G93A rats (175 d) according to the procedures
describedbyDiaz-Amarilla et al. (2011)withminormodiﬁcations.
Adult age-matched non-Tg rats were used as controls. Brieﬂy, ani-
malswere killed by deeply anesthesia, and spinal cordwas dissected
on ice. After the meninges were removed carefully, spinal cord was
chopped ﬁnely and dissociated with 0.25% trypsin in calcium-
free buffer for 5 min at 37◦C. Trypsin treatment was stopped by
adding DMEM/10% (vol/vol) FBS in the presence of 50 μg/mL
DNaseI and mechanical disaggregation by repeated pipetting. The
resulting extract was passed through an 80-μm mesh to elimi-
nate tissue debris and then was spun. The pellet was resuspended
in culture medium [DMEM/10% (vol/vol) FBS, Hepes (3.6 g/L),
penicillin (100 IU/mL), and streptomycin (100 μg/mL)] and
then was plated in a 25-cm2 tissue culture ﬂask. Because large
amounts of fat hindered cell counting, the cells isolated from
individual spinal cords were plated in individual culture ﬂasks.
Culture medium was removed after 24 h and then was replaced
every 48 h.
LEUCINE-METHYL ESTER TREATMENT
Leucine-Methyl Ester (Leu-OMe, Sigma) was prepared in DMEM,
pH adjusted to 7.4. Cultures from transgenic symptomatic rats
were treated 3 days after plated with 25 mM of Leu-OMe during
1 h. Then, the cells were washed three times with PBS and ﬁxed
with cold methanol during 5 min (n = 3).
IMMUNOCYTOCHEMICAL STAINING OF CULTURED CELLS
Cultured cellswereﬁxedwith absolutemethanol at -20◦Cfor 5min
on ice and thenwerewashed three timeswith 10mMPBS (pH7.4).
Non-speciﬁc binding was blocked by incubating ﬁxed cells with
5% BSA in PBS for 1 h at room temperature. Corresponding pri-
mary antibodies were diluted in blocking solution and incubated
overnight at 4◦C in a wet closed chamber. The primary antibodies
for microglia recognition were rabbit anti-Iba1 (1:200, Abcam),
rabbit anti-CD11b (1:200, Abcam), and mouse anti-CD68 (1:300,
Abcam). The antibodies used for astrocyte recognitionweremouse
anti-GFAP (1:500, Sigma), rabbit anti-GFAP (1:500, Sigma),
mouse anti-S100β(1:400, Sigma). After washing, sections were
incubated in a 1,000-fold dilution of secondary antibodies con-
jugated to Alexa Fluor 488 and/or Alexa Fluor 546 (1:1000,
Invitrogen). Antibodies were detected by confocal microscopy
using a confocal Olympus FV300 microscope.
ANALYSIS OF MICROGLIAL MARKERS EXPRESSION
After isolation of the symptomatic spinal cord, cells were plated
in 35-mm dishes at 1.2 × 104 cells/cm2. 7 days after plating,
cells were ﬁxed and stained with microglia speciﬁc markers as
described above. The analysis was performed manually in using
the cell counter tool of the Image J software. Values were expressed
as a percentage ( ± SD) of the total number of DAPI+ nuclei.
Only healthy nuclei with clearly deﬁned limiting membranes were
counted. Cell counts were performed in duplicate.
FORSKOLIN TREATMENT
After 20 days in vitro, 35 mm dishes were treated with 10 μM of
forskolin (FSK; Sigma) during 3 h. Then, the cells were ﬁxed using
cold methanol and stained as described above.
FLOW CYTOMETRIC ISOLATION
After 7 days in vitro the cells were incubated at 37◦C with 0.25%
trypsin without calcium. After 5 min, the cells were harvested in
DMEM/10% (vol/vol) FBS and spun at 250 × g for 10 min. The
resultant pellet was washed three times in PBS at 37◦C. After that,
the cells were re-suspended in blocking solution (PBS; 5% FBS,
and 1% BSA). The cells were labeled at 4◦C for 15 min with mouse
anti-CD11b-FITC (1:100, Abcam) and sorted using the MoFloTM
XDP–Beckman Coulter. After sorting, the cells were re-plated in a
25 cm2 bottle with DMEM/10% FBS.
IMMUNOHISTOCHEMICAL STAINING OF RAT SPINAL CORDS
Animals were deeply anesthetized and transcardial perfusion was
performed with 0.9% saline and 4% paraformaldehyde in 0.1 M
PBS (pH7.2–7.4) at a constant ﬂowof 1mL/min. Fixed spinal cord
was removed, post-ﬁxed by immersion for 24 h, and then trans-
verse sectioned serially (30–50 μm) on a vibrating microtome.
Serial sections were collected in 100 mM PBS for immunohis-
tochemistry. After citrate antigen retrieval, free-ﬂoating sections
were permeabilized for 15 min at room temperature with 0.1%
Triton X-100 in PBS, passed through washing buffered solutions,
blocked with 5% BSA:PBS for 1 h at room temperature, and
incubated overnight at 4◦C in a solution of 0.1% Triton X-100
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and PBS containing the primary antibodies, mouse anti-Iba1
(1:200, Abcam), mouse anti CD163 (1:100, Serotec) for microglia
recognition, and rabbit anti-GFAP (1:500, Sigma) for astrocyte
recognition. A rabbit anti-Ki67 (1:400, Abcam) was used as a
proliferation marker. The expression of nitrotyrosine was recog-
nizedwith amouse anti-NO2-Tyr (1:300,Millipore) antibody. The
immunoreactivity was completely blocked by pre-incubation of
the primary antibody with free nitrotyrosine (10 mM). No anti-
gen retrieval was needed to detect nitrotyrosine. After washing,
sections were incubated in 1:1,000-diluted secondary antibodies
conjugated to Alexa Fluor 488 and/or Alexa Fluor 546 (Invitro-
gen). Antibodies were detected by confocal microscopy using a
confocal Olympus FV300 microscope.
QUANTITATIVE ANALYSIS OF ABA CELLS IN THE DEGENERATING
SPINAL CORD
The number of proliferating cells labeled with Ki67 and also
stained for the astrocytic marker GFAP or microglial marker Iba1
was assessed by counting the respective double-positive cells in the
gray matter of the lumbar cord of symptomatic or asymptomatic
SOD1G93A rats. Quantiﬁcation was performed only in the ven-
tral horn, comparing the cell numbers in Rexed laminae VII and
IX, which display low and high density of large motor neurons,
respectively. Double-positive cells were counted in a perimeter of
100 μm, surrounding motor neurons. The analysis was performed
manually in 10 histological sections per animal (two different rats
for each condition) using the cell counter tool of the Image J
software. Values were expressed as a ratio of double-positive cells
per motor neuron. The number of double-positive cells labeled
with Iba1 or CD163 and GFAP assessed by counting the respec-
tive double-positive cells in the gray matter of the lumbar cord
of asymptomatic and symptomatic SOD1G93A rats. Quantiﬁca-
tion was performed only in the ventral horn, comparing the cell
numbers in Rexed laminaeVII and IX, which display low and high
density of largemotor neurons, respectively. Values were expressed
as the number of double-positive cells per mm2.
RESULTS
GLIAL PROLIFERATION ADJACENT TO DEGENERATING MOTOR
NEURONS
The number of proliferating glia as identiﬁed by Ki67+ nuclei
sharply increased in the ventral horn of SOD1G93A symptomatic
rats and accumulated near surviving motor neurons as well as
at sites of apparent motor neuron loss (Figure 1). This pop-
ulation of Ki67+ cells had large cell bodies (30–50 μm) with
processes embracing motor neurons and expressed GFAP and
Iba1 (Figure 1A, upper panels). Both Ki67/GFAP and Ki67/Iba1-
positive cells displayed morphological features of AbA cells in
culture (Diaz-Amarilla et al., 2011) and could be easily dif-
ferentiated from astrocytes and microglia from non-transgenic
or Tg asymptomatic rat’s spinal cord. These large GFAP/Ki67
or Iba1/Ki67 cells were rarely observed in asymptomatic or
non-transgenic rats (Figure 1A, lower panels). Due to the
antigen retrieval procedure, motor neuron cell bodies were non-
speciﬁcally labeled with Ki67 in all experimental conditions. The
ratio of GFAP/Ki67 cells and Iba1/Ki67 cells to motor neu-
rons in symptomatic rats was 2.7 and 2.9 respectively, whereas
the ratio was < 0.3 in asymptomatic animals for both markers
(Figure 1B).
CO-EXPRESSION OF MICROGLIAL AND ASTROCYTIC MARKERS IN ABA
CELLS
While astrocytes and microglial cells constituted two separate
cell populations in asymptomatic rats, being typically detected
by GFAP and Iba1 respectively, most AbA cells surrounding the
motor neurons in symptomatic rats were surprisingly co-labeled
with both markers as well as CD163 (Figure 2A). 70% of the
GFAP-positive AbA cells in the ventral horn exhibited microglial
markers, as compared as <1% in asymptomatic rats. The num-
ber of cells labeled with Iba1/GFAP or CD163/GFAP was similar
(∼100 cells per mm2) in symptomatic rats, suggesting the same
cells expressed both microglial markers (Figure 2B). Detection of
the microglial markers required the use of strong antigen retrieval
methods, which made motor neuron to artifactually stained with
CD163.
Both peri-neuronal AbA cells as well as motor neurons were
strongly stained for nitrotyrosine in symptomatic rats, consistent
with the productionof peroxynitrite (Figure 2C). This immunore-
activity was completely blocked by preincubation of the primary
antibody with free nitrotyrosine (data not shown).
CHARACTERIZATION OF FIRST STAGES OF ABA CELLS IN VITRO
Because AbA cells can be cultured from symptomatic rats (Diaz-
Amarilla et al., 2011), we determined the time course of microglial
and astrocytic marker expression. Soon after primary cultures
of spinal cord were established (DIV2–DIV7), most of the cells
displayed the morphology of phagocytic microglia and were ﬂu-
orescently labeled with the microglia markers CD11b, CD68,
and Iba1 (Figure 3A). The detailed morphology of cultured
cells closely corresponded to the typical features of microglial
cells previously reported (Kreutzberg, 1996; Figure 3B). No
immunoreactivity for GFAP or S100β was detected in cultures
since the establishment of cultures and until 10–12 DIV (data
not shown). Microglial cells were also analyzed by ﬂow cytome-
try (FACS) using FITC-labeled CD11b antibodies. FACS analysis
showed that > 99% of cells of the primary spinal cord culture of
symptomatic rats belonged to the microglia lineage. The purity of
this culture was also determined by counting CD68+ and Iba1+
cells and found to be> 98% (Figure 3C).
PHENOTYPIC TRANSFORMATION OF MICROGLIA INTO ABA CELLS
IN VITRO
To conﬁrm that AbA cells were derived from microglia cell
progenitors, CD11b+ expressing cells were FACS-sorted and re-
established in culture until DIV15. Sorted cells displayed the typ-
ical microglia morphology and phenotypic marker until DIV10.
This population of cells progressively transitioned into astrocyte-
like cells forming monolayers between DIV10 and DIV15, while
losing the morphology and phenotypic markers of microglia
(Figure 4A). At this time, transition zones in the border separating
themicroglial and the astrocyte-like cells expressedbothmicroglial
(Iba1 and CD11b) and astrocytic (GFAP) markers (Figure 4B).
These transition zones were transient because most cells expressed
S100β without microglial markers by DIV15. The treatment of
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FIGURE 1 | Characterization of proliferative astrocytes and microglia in
the degenerating lumbar spinal cord. (A) Photomicrographs showing
GFAP/Ki67 and Iba1/Ki67 stained lumbar spinal cord sections measured in
symptomatic (upper panels), asymptomatic (middle panels) SOD1G93A rats,
and non-transgenic rats (lower panels). Low magniﬁcation panels show the
notorious increase in the number of Ki67+ red nuclei and the appearance
of large GFAP+ and Iba1+ cells (green) in the symptomatic rats, as
compared to low cell proliferation in asymptomatic or non-Tg rats. A white
line indicates the border between white and grey matter. The high
magniﬁcation images show that GFAP/Ki67 and Iba1/Ki67 cells are typically
located around the motor neurons (indicated as dotted lines) and their
processes closely embrace the neuronal cell body. The arrows indicate
double-labeled cells. Note the unspeciﬁc binding of Ki67 antibody to motor
neuron cell bodies. (B) Ratio of GFAP/Ki67 and Iba1/Ki67-positive cells per
motor neuron in symptomatic and asymptomatic rats. The scheme at the
left shows the methods used to count the cells in a perimeter of 100 μm
around motor neurons. The counting was performed in 10 histological
sections per animal. Two different rats were used for each condition. Data
are shown as mean ± SD; *P < 0.05. Scale bars: 100 μm for low
magniﬁcation panels; 20 μm for high magniﬁcation panels.
the cultures with 10 μM FSK, which is known to induce astro-
cytic processes growth and differentiation (Abe and Saito, 1997),
accelerated the transition frommicroglia toAbA cells, while down-
regulating the expression of Iba1 and promoting the growth of
processes stained with GFAP (Figure 4C). To further conﬁrm the
microglia to astrocyte phenotypic switch, we treated the cultures
with Leu-OMe, a compound used to selectively deplete microglia
from primary cell cultures (Uliasz et al., 2012). Figure 4D shows
that microglia from ALS rats were completely killed by 25 mM
of Leu-OMe at DIV3, whereas there was no toxicity at DIV20
after the cells had undergone the phenotypic transition to an AbA
morphology.
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FIGURE 2 | Concurrent expression of microglia and astrocytic markers
in AbA cells.(A) Representative image of GFAP (red), Iba1 (green), and
CD163 (green) in lumbar spinal cord sections from transgenic asymptomatic
(Tg-asymp) and symptomatic (Tg-sympt) SOD1G93A rats. Dotted lines
indicate motor neuron cells bodies, which artifactually stained for CD163.
Note that microglia and astrocytes in asymptomatic rat expressed GFAP
and Iba1 in well-segregated cell populations. In comparison, most of the
Iba1+ and CD163+ cells also expressed GFAP in symptomatic animals
(arrows). (B) Quantiﬁcation of cells expressing Iba1/GFAP and CD163/GFAP
in the lumbar spinal cord. The counting was performed in 10 histological
sections per animal. Two different rats were used for each condition. Data
are shown as mean ± SD; *P < 0.05. (C) Representative confocal
immunostaining against GFAP (red) and nitrotyrosine (NO2−Tyr, green) in
the ventral horn of a symptomatic rat showing the intense nitration of
Perineuronal AbA cells (arrows). Scale bars: 20 μm.
DISCUSSION
Glial cells expressing mutant SOD1 are now well established to
be toxic to motor neurons in rodent models as well as in ALS
patients (Barbeito et al., 2004; Nagai et al., 2007; Yamanaka et al.,
2008; Haidet-Phillips et al., 2011). AbA cells are the most toxic
FIGURE 3 | Characterization of first stages of AbA cells in vitro.
Primary cultures of the spinal cord of symptomatic rats were established as
in (Diaz-Amarilla et al., 2011) and the cell phenotypes were analyzed on
DIV7. (A)The upper panel shows a representative phase-contrast image of
the culture at DIV7. The inset shows the same culture obtained from non-Tg
littermates where no cells could be grown. The lower panels show confocal
images of cells immunostained for typical microglia markers such as
CD11b, CD68, and Iba1 at 7 DIV. Scale bars: 50 μm. (B) Characterization of
different typical microglia phenotypes present at 7 DIV, cultured fromTg
symptomatic rats. Scale bar: 25 μm. (C) Quantiﬁcation of the microglia
markers expression (CD11b, CD68, and Iba1) in culture at 7 DIV, counting
cell positive for microglia marker respect to the total number of nuclei
labeled with DAPI (upper panel). Typical data from ﬂow cytometry showing
that 99% of cells were CD11b+. The data are representative of three
independent experiments.
cells yet identiﬁed to motor neurons (Diaz-Amarilla et al., 2011).
These distinctive glial cells are directly associated with motor neu-
ron disease, because they actively proliferate after the onset of
progressive paralysis and make intimate contact with degenerat-
ing motor neurons. By analyzing the population of proliferating
Ki67+ glial cells in the ventral horn of symptomatic SOD1 rats, we
found thatAbA cellsmost likely originate frommicroglia. Notably,
puriﬁed microglia isolated from the spinal cord of symptomatic
rats spontaneously transformed into AbA cells.
The extremely rapid progression of paralysis in SOD1G93A rats
is characterized by prominent neuroinﬂammation associated with
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FIGURE 4 | Phenotypic transition of microglia into AbA cells in culture.
(A) Microglia cell cultures (7 DIV) from symptomatic spinal cord were
dissociated and stained with FITC-labeled CD11b. After FACS sorting, cells
were re-plated and analyzed for phenotypic transition at DIV15. Scale bar:
50 μm. (B) Confocal image showing transition zones observed at 15 DIV.
Note the segregation of astrocytic S100β staining with the microglia Iba1 or
CD11b markers, which coincides with the morphological change of cells. The
co-localization of astrocytic and microglia markers was found in a few cells in
the border between these zones. Scale bar: 50 μm. (C)Treatment of cultures
at DIV15 with foskolin (10 μM, 3 h) down regulated Iba1 expression and
stimulated GFAP expression and growth of processes. Scale bars: 50 μm.
(D) Differential effect of 25 μM of Leucine-Methyl Ester (Leu-OMe) before
and after the phenotypic transition. Treatment with Leu-OMe was applied to
cultures at DIV3 and DIV20 to assess the toxicity. Toxicity of Leu-OMe was
restricted to the microglia phenotype. This experiment was repeated with
three independent isolations of AbA cells. Scale bars: 20 μm
microglia activation (Sanagi et al., 2010; Philips and Robberecht,
2011). This inﬂammatory response is consistent with the sharp
increase in cell proliferation others and we have observed with
Ki67-staining in symptomatic animals (Schaefer et al., 2005; Pun
et al., 2006). Previously, BrdU incorporation was used to demon-
strate increased cell proliferation in ALS rats of NG2-positive glial
progenitor cells (Magnus et al., 2008), which can potentially dif-
ferentiate into astrocytes. Our results indicate that microglia more
likely gave rise toAbA cells expressing astrocyticmarkers in regions
adjacent to motor neurons.
The ﬁnding that spinal AbA cells co-express astrocytic GFAP
with two different microglia markers Iba1 or CD163 was sur-
prising because such a mixed phenotype is rarely observed.
Co-expression of both markers has been observed in neoplastic
glioblastoma multiforme cells (Huysentruyt et al., 2011; Persson
and Englund, 2012). These human astroglial tumor cells seem
to acquire phagocytic properties as a consequence of the dra-
matic inﬂammatory conditions occurring in tumors (Persson
and Englund, 2012). Similarly, spinal AbA cells may origi-
nate from a phenotypic transition of inﬂammatory microglia
into astrocytes-like cells in the degenerating cellular environ-
ment of the ventral horn. Other reports have shown aberrant
features of microglial cells in symptomatic SOD1G93A rats, includ-
ing formation of microglia clusters (Howland et al., 2002) and
multi-nucleated giant cells (Fendrick et al., 2007). Based on the
morphology, localization, high proliferation rate, and other phe-
notypic features, spinal AbA cells are distinct from previously
described M1 or M2 microglia (Kigerl et al., 2009; Durafourt et al.,
2012; Liao et al., 2012). It is uncertain whether the phenotypic
transition is speciﬁc for mutant SOD1 microglia or might also
be observed in other CNS insults where phagocytic microglia
accumulate around dying neurons (Beyer et al., 2000; Sanagi
et al., 2010; Neher et al., 2012). For example, ameboid microglia-
like cells expressing markers of oligodendrocyte and monocyte
lineages have been described in hippocampus following acute neu-
ronal damage (Fiedorowicz et al., 2008). AbA cells represent a
novel pathological phenotype of microglia/macrophages derived
from their prominent plasticity following activation (Schwartz
et al., 2006; Luo and Chen, 2012). This phenotypic transfor-
mation of microglia may explain why the ablation of dividing
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astrocytes did not alter astrogliosis in SOD1 mice (Lepore et al.,
2008).
Further evidence that AbA cells derive from activated microglia
was provided in cell culture experiments showing that puri-
ﬁed endogenous microglia can transition to astrocyte-like cells.
Microglia expressing CD11b, Iba1, and CD68 represented more
than 98% of cells isolated from the spinal cord of symptomatic
SOD1G93A rats. Moreover, FACS sorting of these cells usingCD11b
antibodies resulted in typical microglia cultures that also transi-
tioned to AbA cells after 2 weeks, showing not only that AbA
cells are originated from microglia but also the phenotypic change
occurs in vitro.
Because the phenotypic switch is associated to sustained cell
proliferation and a critical cell density, we suggest that inﬂam-
matory mediators secreted by the activated microglia induced
the transformation. Previous reports have shown the ability of
microglia to be progenitors for different neural cell types, includ-
ing astrocytes in vitro (Yokoyama et al., 2004). This property in
turn may be related to their hematopoietic origin (Yokoyama et al.,
2006). Compared to AbA cells growing in the degenerating spinal
cord, the concurrent expression of astrocytic and microglia mark-
ers by cultured AbA cells is only transiently in restricted to the
borders of the transition zones. Therefore, it appears that activated
microglial cells in degenerating spinal cord are prone to transition
to astrocyte-like phenotype both in culture conditions as well as in
vivo, in the cellular niche surrounding the motor neurons. These
cells may play a role in the killing and subsequent phagocytosis of
motor neurons.
Spinal AbA cells also show a number of aberrant features
includinghigh levels of S100β andCx43 expression (Diaz-Amarilla
et al., 2011) that may be relevant for neuronal toxicity through
secreted S100 proteins aswell as extracellularATP released through
connexin hemichannels. Activation of the extracellularATP recep-
tor/channel P2X7has recently been shown to inducemotorneuron
death and to induce the neurotoxic phenotypes of astrocytes in
culture (Gandelman et al., 2010, 2013). Furthermore, endogenous
nitration of tyrosine near the ATP binding pocket of HSP90 acti-
vates P2X7, which induces motor neuron apoptosis (Franco et al.,
2013).
We also showed that spinal AbA cells are strongly stained for
nitrotyrosine especially in the distal perineuronal processes, con-
sistent with the production of peroxynitrite. Microglia bearing
mutant SOD1 has been shown to damage motor neurons through
the production of peroxynitrite (Thonhoff et al., 2012).Because
their microglia origin, spinal AbA cells may have primed to gener-
ate superoxide and hence peroxynitrite on the exterior face of the
plasma membrane in close proximity to motor neurons (Beckman
et al., 2001).
CONCLUSION
Taken together, the present work supports the concept that aber-
rant astrocyte-like cells in the degenerating spinal cord are derived
from activated microglia that proliferate around damaged motor
neurons. The present study provides evidence that microglia iso-
lated from the spinal cord of ALS–SOD rats developing paralysis
have the potential to transition into an astrocyte-like phenotype.
The proliferating spinal AbA cells concurrently express markers
of both microglia and astrocytes lineages. Because the appearance
of AbA cells is closely associated to the progression of paraly-
sis in SOD1G93A rats, a better understanding of the mediators
inducing the phenotypic transition may provide another avenue
of intervention to slow the progressive spread of disease in ALS
patients.
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